Prof. Dr. apt. Drs. Yufri Aldi, M.Si, is a Professor in Pharmacology Research focusing on Pharmacology, Immunology, and Biomedicine with a speciality in the search for new drugs from natural ingredients that are immunomodulatory to the body's immunity. As a Pharmacologist, Prof. Dr. apt. Yufri Aldi, M.Si, also conducts research examining drug safety in pre-clinical and clinical trials. The results of this research will produce phytopharmaceutical drugs that can increase the body's immunity, which is a substantial contribution to human life. In addition, Prof. Dr. apt. Drs, Yufri Aldi, M.Si. also conducts Clinical Pharmacy research that discusses the effects of drugs and their interactions on patients and their rationale.

Prof. (Dr.) Nalini Kanta Sahoo is an accomplished academician and researcher with over 18 years of experience in academics, administration, training, accreditation, and research. He currently serves as Director and Principal at MIT College of Pharmacy, Moradabad (affiliated to AKTU), and previously held the role of Principal at SRM College of Pharmacy, Modinagar. He is also an Adjunct and Visiting Professor at D.Y. Patil Deemed University, Navi Mumbai.
Dr. Sahoo holds a Ph.D. from Siksha ‘O’ Anusandhan University (NIRF Rank 19) and completed a postdoctoral fellowship at the Industrial University of Ho Chi Minh City, Vietnam. He has authored 88+ research articles, published 13 patents (with six design patents granted), and contributed to several internationally acclaimed books and chapters. He is a recipient of numerous awards including the Best Teacher Award (ZIIEI), Best Professor in Pharmacy (ITAP), and the InSc HOD of the Year Award. Dr. Sahoo is involved in several advisory and editorial boards worldwide and actively contributes as a corporate trainer, NBA/NAAC coordinator, and entrepreneurship educator.
He is a lifetime member of several prestigious academic and scientific organizations and continues to play a key role in research, innovation, and academic excellence in the pharmaceutical sciences.

Professor Dr Palanirajan Vijayaraj Kumar is a Head of Pharmaceutical Technology Department, Faculty of Pharmaceutical Sciences at UCSI University. He has completed the Ph.D in Dr. HS Gour University (A Central University, India) in 2007. After his PhD he has continued teaching and research career and guided several undergraduate, postgraduate and 10 PhD student research projects. He has 18 years of experience in both teaching and research, and he has published 67 peer-reviewed papers in addition to two patents. In 2010, his contributions to scientific society were recognized with Pharma Help Line Society, India and he have received Young Scientist Award. Further, his continuous contribution in research, he has received the Promising researcher Award from UCSI University in 2016, Malaysia. In 2017, he received a Brown medal for developing Carica Papaya capsules for dengue patients from the Ministry of Higher Education, Malaysia. In 2018 he has received an InnoCentive Award from USA, for developing Novel Cardiac-Specific Ligands for Targeted Drug Delivery sponsored by SERVIER international and independent pharmaceutical company governed by a non-profit foundation from France. In 2020, one of his formulations received Silver Medal in ITEX2020 (32nd International Invention, Innovation Market Place for Innovation and Technology Exhibition, Malaysia). Again in 2021 MTE one his team research product "Transdermal Microneedles for a Recombinant Human Keratinocyte Growth Factor" received silver medal and Award of Merit in conjunction with The Malaysia-Croatia Technology Exchange. Also, his team members developed the mimotope-based vaccine delivery system for treating KRAS-positive colorectal cancer and the chitosan nanoparticle formulation for use in treating acute lung injury, which is protected under a Malaysian patent.

Dr. Palanisamy Sivanandy is an eminent academician and researcher with more than 19 years of teaching and research experience. He has more than 27 years of experience in the pharmacy field. Currently, Dr Palanisamy has been working as a Programme Director at the International Medical University, Kuala Lumpur, Malaysia since 2014. He started his career as a Dispensing pharmacist in the year 1997 as a Diploma Pharmacist; in 2005 he completed his Pharmacy Under graduation (B.Pharm) from the Madurai Medical College, Tamilnadu; in 2007 he obtained his Post Graduation (M.Pharm) in Pharmacy Practice from Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu. He completed his Ph.D., in the year 2013 from the prestigious Tamil Nadu Dr. MGR Medical University, Chennai, and the Good Clinical Practice Licensure Exam from the Ministry of Health (MoH), Malaysia in 2014. He has published more than 100 research and review papers in various national and internationally indexed peer-reviewed journals and has been serving as Chief editor and an editorial board member of repute for more than 10 international journals. He has received many grants from the Indian Council of Medical Research, New Delhi, India; Department of Science & Technology, New Delhi, India; Centre for International Co- Operation in Science, Chennai, India; and International Medical University, Kuala Lumpur, Malaysia. He has presented many research papers in conferences in various countries like Turkey, the United States of America, South Korea, Singapore, Thailand, Indonesia, the Philippines, India, and Malaysia. Dr. Palanisamy has been awarded the “Outstanding Researcher in Pharmacology Award” in 2018, “Education Leadership Award” in 2019, “Global Knowledge Management Award” in 2020, “Dynamic Pharma Teacher Award” in 2020, “IMU Achievement Award” in 2020, “AKS Global Faculty Award” in 2021, “Leadership in Community Service (Individual and Group) Awards” in 2021, “Business Process Improvement Award” in 2021, “IMU SoP - Book Chapters Award” in 2021, “Distinguished Professor Award” in 2021, “National Education Excellence Achievers Award” in 2022, “Award of Leadership in Programme Management”, in 2022, “Best Academician” award in 2022, “Award of Leadership in Programme Management” in 2023, elected as the FELLOW of the Royal Society for Public Health (FRSPH), UK, in August 2023, “Teaching Excellence Award” in 2024, and “IMU- Long-Service Award in 2024, “Award of Leadership in Programme Management” in 2024,“Academic Board Member” by Global Open Share Publishing Pty Ltd, Alfredton, Australia in 2025.His main areas of interest are Cardiovascular and diabetic medications, Oncology, Pharmacovigilance, Drug Safety Monitoring, Prescription Auditing, Clinical Research and Development, Cerebrovascular complications and rehabilitation, Clinical Trials, Patient Safety, Social and Administrative Pharmacy, and Falls risk medications.